Healthcare & Lifesciences
Praxis Logo

Cipla expands diagnostics portfolio, launches point-of-care testing device

Know more
Healthcare & Lifesciences

Cipla expands diagnostics portfolio, launches point-of-care testing device

18 Jan 2023

1 min read
As investments continue to flow in the diganostic segment with pharma companies penetrating the space, according to a report released by Praxis Global Alliance, a global management consulting and advisory services firm, the Indian medical diagnostic industry is expected to grow at around 14 per cent touching $20 billion by 2026 from $10 billion in 2021.

Disclaimer: The text, images and content here have been reproduced from the original publisher. Praxian Global Private Limited does not claim any ownership or right to use of this content and the rights belong to the publisher. We have contributed our perspectives, which are often proprietary, to the content publisher. We or the publisher have no obligation to update or refresh the content or our perspectives shared herein.

Ready to talk?

I want to talk to your experts in:

We work with ambitious leaders and transformative clients who are defining the future. Together, we achieve extraordinary outcomes.